BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16341033)

  • 21. Detection of NPM/MLF1 fusion in t(3;5)-positive acute myeloid leukemia and myelodysplasia.
    Arber DA; Chang KL; Lyda MH; Bedell V; Spielberger R; Slovak ML
    Hum Pathol; 2003 Aug; 34(8):809-13. PubMed ID: 14506644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increase sensitivity to chemotherapeutical agents and cytoplasmatic interaction between NPM leukemic mutant and NF-kappaB in AML carrying NPM1 mutations.
    Cilloni D; Messa F; Rosso V; Arruga F; Defilippi I; Carturan S; Catalano R; Pautasso M; Panuzzo C; Nicoli P; Messa E; Morotti A; Iacobucci I; Martinelli G; Bracco E; Saglio G
    Leukemia; 2008 Jun; 22(6):1234-40. PubMed ID: 18401421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NPM and NPM-MLF1 interact with chromatin remodeling complexes and influence their recruitment to specific genes.
    Darracq A; Pak H; Bourgoin V; Zmiri F; Dellaire G; Affar EB; Milot E
    PLoS Genet; 2019 Nov; 15(11):e1008463. PubMed ID: 31675375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rearrangement of the Chromatin Organizer Special AT-rich Binding Protein 1 Gene,
    Torkildsen S; Brunetti M; Gorunova L; Spetalen S; Beiske K; Heim S; Panagopoulos I
    Anticancer Res; 2017 Feb; 37(2):693-698. PubMed ID: 28179318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of an NPM1/MLF1 D-FISH probe set for the detection of t(3;5)(q25;q35) identified in patients with acute myeloid leukemia.
    Aypar U; Knudson RA; Pearce KE; Wiktor AE; Ketterling RP
    J Mol Diagn; 2014 Sep; 16(5):527-532. PubMed ID: 25027285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Translocation (3;5)(q21;q34) in erythroleukemia: a molecular and in situ hybridization study.
    Kwong YL
    Cancer Genet Cytogenet; 1998 May; 103(1):15-9. PubMed ID: 9595039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of MOZ-CBP fusion in acute myeloid leukemia with 8;16 translocation.
    Crowley JA; Wang Y; Rapoport AP; Ning Y
    Leukemia; 2005 Dec; 19(12):2344-5. PubMed ID: 16193081
    [No Abstract]   [Full Text] [Related]  

  • 29. A novel chromosomal translocation t(3;7)(q26;q21) in myeloid leukemia resulting in overexpression of EVI1.
    Storlazzi CT; Anelli L; Albano F; Zagaria A; Ventura M; Rocchi M; Panagopoulos I; Pannunzio A; Ottaviani E; Liso V; Specchia G
    Ann Hematol; 2004 Feb; 83(2):78-83. PubMed ID: 14551738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant.
    Colombo E; Martinelli P; Zamponi R; Shing DC; Bonetti P; Luzi L; Volorio S; Bernard L; Pruneri G; Alcalay M; Pelicci PG
    Cancer Res; 2006 Mar; 66(6):3044-50. PubMed ID: 16540653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a real-time RT-PCR assay for the quantification of the most frequent MLL/AF9 fusion types resulting from translocation t(9;11)(p22;q23) in acute myeloid leukemia.
    Scholl C; Breitinger H; Schlenk RF; Döhner H; Fröhling S; Döhner K;
    Genes Chromosomes Cancer; 2003 Nov; 38(3):274-80. PubMed ID: 14506704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early acute myeloblastic leukemia treatment for childhood myelodysplastic syndrome with t(3;5) (NPM/MLF1).
    Sevilla J; Fernández-Plaza S; Lassaletta A; González-Vicent M; Contra T; Madero L
    J Pediatr Hematol Oncol; 2007 Dec; 29(12):839-40. PubMed ID: 18090933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Common gene expression signatures in t(8;21)- and inv(16)-acute myeloid leukaemia.
    Ichikawa H; Tanabe K; Mizushima H; Hayashi Y; Mizutani S; Ishii E; Hongo T; Kikuchi A; Satake M
    Br J Haematol; 2006 Nov; 135(3):336-47. PubMed ID: 16989659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features.
    Falini B; Nicoletti I; Martelli MF; Mecucci C
    Blood; 2007 Feb; 109(3):874-85. PubMed ID: 17008539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MYST3/CREBBP (MOZ/CBP) and CREBBP/MYST3 (CBP/MOZ) transcripts in AML with t(8;16)(p11;p13).
    Schmidt HH
    Genes Chromosomes Cancer; 2005 Feb; 42(2):207-8; author reply 209. PubMed ID: 15540217
    [No Abstract]   [Full Text] [Related]  

  • 36. t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy.
    Yin CC; Cortes J; Barkoh B; Hayes K; Kantarjian H; Jones D
    Cancer; 2006 Apr; 106(8):1730-8. PubMed ID: 16532439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+ AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance.
    Alcalay M; Tiacci E; Bergomas R; Bigerna B; Venturini E; Minardi SP; Meani N; Diverio D; Bernard L; Tizzoni L; Volorio S; Luzi L; Colombo E; Lo Coco F; Mecucci C; Falini B; Pelicci PG
    Blood; 2005 Aug; 106(3):899-902. PubMed ID: 15831697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PML/RARA rearrangement associated with a t(15;19;17) in a case of acute myeloid leukemia with abundant myelocytes with salmon-pink cytoplasm.
    Kim IS; Kim HJ; Choung HS; Jung CW; Kim JW; Kim SH
    Cancer Genet Cytogenet; 2006 Aug; 169(1):81-2. PubMed ID: 16875944
    [No Abstract]   [Full Text] [Related]  

  • 39. Fusion gene transcripts and Ig/TCR gene rearrangements are complementary but infrequent targets for PCR-based detection of minimal residual disease in acute myeloid leukemia.
    Boeckx N; Willemse MJ; Szczepanski T; van der Velden VH; Langerak AW; Vandekerckhove P; van Dongen JJ
    Leukemia; 2002 Mar; 16(3):368-75. PubMed ID: 11896540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment of a novel human myeloid leukemia cell line, AMU-AML1, carrying t(12;22)(p13;q11) without chimeric MN1-TEL and with high expression of MN1.
    Gotou M; Hanamura I; Nagoshi H; Wakabayashi M; Sakamoto N; Tsunekawa N; Horio T; Goto M; Mizuno S; Takahashi M; Suganuma K; Yamamoto H; Hiramatsu A; Watarai M; Shikami M; Imamura A; Mihara H; Taki T; Miwa H; Taniwaki M; Nitta M
    Genes Chromosomes Cancer; 2012 Jan; 51(1):42-53. PubMed ID: 21965128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.